APO Research
Talk to an analyst

APO RESEARCH · REPORT

BCG Tuberculosis (TB) Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global BCG Tuberculosis (TB) Vaccine Market Outlook and Growth Opportunities 2026

21 December 2025194 pages

Choose your research edition.

Industry ResearchBCG Tuberculosis (TB) Vaccine Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal BCG Tuberculosis (TB) Vaccine Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal BCG Tuberculosis (TB) Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal BCG Tuberculosis (TB) Vaccine Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal BCG Tuberculosis (TB) Vaccine Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global BCG Tuberculosis (TB) Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for BCG Tuberculosis (TB) Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for BCG Tuberculosis (TB) Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for BCG Tuberculosis (TB) Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the BCG Tuberculosis (TB) Vaccine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the BCG Tuberculosis (TB) Vaccine market include China National Biotec, Sanofi Pasteur, Merck, Serum Institute of India, Japan BCG Lab, Intervax and GSBPL, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global BCG Tuberculosis (TB) Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of BCG Tuberculosis (TB) Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents BCG Tuberculosis (TB) Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the BCG Tuberculosis (TB) Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

BCG Tuberculosis (TB) Vaccine Segment by Company

China National Biotec

Sanofi Pasteur

Merck

Serum Institute of India

Japan BCG Lab

Intervax

GSBPL

BCG Tuberculosis (TB) Vaccine Segment by Type

Immune BCG

Therapy BCG

BCG Tuberculosis (TB) Vaccine Segment by Application

Hospital

Clinic

BCG Tuberculosis (TB) Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global BCG Tuberculosis (TB) Vaccine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions BCG Tuberculosis (TB) Vaccine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify BCG Tuberculosis (TB) Vaccine significant trends, drivers, influence factors in global and regions.

6. To analyze BCG Tuberculosis (TB) Vaccine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global BCG Tuberculosis (TB) Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of BCG Tuberculosis (TB) Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of BCG Tuberculosis (TB) Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the BCG Tuberculosis (TB) Vaccine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global BCG Tuberculosis (TB) Vaccine industry.

Chapter 3: Detailed analysis of BCG Tuberculosis (TB) Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of BCG Tuberculosis (TB) Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of BCG Tuberculosis (TB) Vaccine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. BCG Tuberculosis (TB) Vaccine Industry Trends Table 2. BCG Tuberculosis (TB) Vaccine Industry Drivers Table 3. BCG Tuberculosis (TB) Vaccine Industry Opportunities and Challenges Table 4. BCG Tuberculosis (TB) Vaccine Industry Restraints Table 5. Global BCG Tuberculosis (TB) Vaccine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global BCG Tuberculosis (TB) Vaccine Revenue Share by Company (2021-2026) Table 7. Global BCG Tuberculosis (TB) Vaccine Sales Volume by Company (k units) & (2021-2026) Table 8. Global BCG Tuberculosis (TB) Vaccine Sales Volume Share by Company (2021-2026) Table 9. Global BCG Tuberculosis (TB) Vaccine Average Price (US$/unit) of Company (2021-2026) Table 10. Global BCG Tuberculosis (TB) Vaccine Company Ranking, (2024-2026) & (USD Million) Table 11. Global BCG Tuberculosis (TB) Vaccine Key Company Manufacturing Base & Headquarters Table 12. Global BCG Tuberculosis (TB) Vaccine Company, Product Type & Application Table 13. Global BCG Tuberculosis (TB) Vaccine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global BCG Tuberculosis (TB) Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Immune BCG Table 18. Significant Companies of Therapy BCG Table 19. Global BCG Tuberculosis (TB) Vaccine Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global BCG Tuberculosis (TB) Vaccine Sales Volume by Type (2021-2026) & (k units) Table 21. Global BCG Tuberculosis (TB) Vaccine Sales Volume by Type (2027-2032) & (k units) Table 22. Global BCG Tuberculosis (TB) Vaccine Sales Volume Share by Type (2021-2026) Table 23. Global BCG Tuberculosis (TB) Vaccine Sales Volume Share by Type (2027-2032) Table 24. Global BCG Tuberculosis (TB) Vaccine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global BCG Tuberculosis (TB) Vaccine Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global BCG Tuberculosis (TB) Vaccine Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global BCG Tuberculosis (TB) Vaccine Sales Value Share by Type (2021-2026) Table 28. Global BCG Tuberculosis (TB) Vaccine Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Clinic Table 31. Global BCG Tuberculosis (TB) Vaccine Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global BCG Tuberculosis (TB) Vaccine Sales Volume by Application (2021-2026) & (k units) Table 33. Global BCG Tuberculosis (TB) Vaccine Sales Volume by Application (2027-2032) & (k units) Table 34. Global BCG Tuberculosis (TB) Vaccine Sales Volume Share by Application (2021-2026) Table 35. Global BCG Tuberculosis (TB) Vaccine Sales Volume Share by Application (2027-2032) Table 36. Global BCG Tuberculosis (TB) Vaccine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global BCG Tuberculosis (TB) Vaccine Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global BCG Tuberculosis (TB) Vaccine Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global BCG Tuberculosis (TB) Vaccine Sales Value Share by Application (2021-2026) Table 40. Global BCG Tuberculosis (TB) Vaccine Sales Value Share by Application (2027-2032) Table 41. Global BCG Tuberculosis (TB) Vaccine Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global BCG Tuberculosis (TB) Vaccine Sales by Region (2021-2026) & (k units) Table 43. Global BCG Tuberculosis (TB) Vaccine Sales Market Share by Region (2021-2026) Table 44. Global BCG Tuberculosis (TB) Vaccine Sales by Region (2027-2032) & (k units) Table 45. Global BCG Tuberculosis (TB) Vaccine Sales Market Share by Region (2027-2032) Table 46. Global BCG Tuberculosis (TB) Vaccine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global BCG Tuberculosis (TB) Vaccine Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global BCG Tuberculosis (TB) Vaccine Sales Value Share by Region (2021-2026) Table 49. Global BCG Tuberculosis (TB) Vaccine Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global BCG Tuberculosis (TB) Vaccine Sales Value Share by Region (2027-2032) Table 51. Global BCG Tuberculosis (TB) Vaccine Market Average Price (US$/unit) by Region (2021-2026) Table 52. Global BCG Tuberculosis (TB) Vaccine Market Average Price (US$/unit) by Region (2027-2032) Table 53. Global BCG Tuberculosis (TB) Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Global BCG Tuberculosis (TB) Vaccine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global BCG Tuberculosis (TB) Vaccine Sales by Country (2021-2026) & (k units) Table 56. Global BCG Tuberculosis (TB) Vaccine Sales Market Share by Country (2021-2026) Table 57. Global BCG Tuberculosis (TB) Vaccine Sales by Country (2027-2032) & (k units) Table 58. Global BCG Tuberculosis (TB) Vaccine Sales Market Share by Country (2027-2032) Table 59. Global BCG Tuberculosis (TB) Vaccine Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global BCG Tuberculosis (TB) Vaccine Sales Value Market Share by Country (2021-2026) Table 61. Global BCG Tuberculosis (TB) Vaccine Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global BCG Tuberculosis (TB) Vaccine Sales Value Market Share by Country (2027-2032) Table 63. China National Biotec Company Information Table 64. China National Biotec Business Overview Table 65. China National Biotec BCG Tuberculosis (TB) Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. China National Biotec BCG Tuberculosis (TB) Vaccine Product Portfolio Table 67. China National Biotec Recent Development Table 68. Sanofi Pasteur Company Information Table 69. Sanofi Pasteur Business Overview Table 70. Sanofi Pasteur BCG Tuberculosis (TB) Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Sanofi Pasteur BCG Tuberculosis (TB) Vaccine Product Portfolio Table 72. Sanofi Pasteur Recent Development Table 73. Merck Company Information Table 74. Merck Business Overview Table 75. Merck BCG Tuberculosis (TB) Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Merck BCG Tuberculosis (TB) Vaccine Product Portfolio Table 77. Merck Recent Development Table 78. Serum Institute of India Company Information Table 79. Serum Institute of India Business Overview Table 80. Serum Institute of India BCG Tuberculosis (TB) Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Serum Institute of India BCG Tuberculosis (TB) Vaccine Product Portfolio Table 82. Serum Institute of India Recent Development Table 83. Japan BCG Lab Company Information Table 84. Japan BCG Lab Business Overview Table 85. Japan BCG Lab BCG Tuberculosis (TB) Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Japan BCG Lab BCG Tuberculosis (TB) Vaccine Product Portfolio Table 87. Japan BCG Lab Recent Development Table 88. Intervax Company Information Table 89. Intervax Business Overview Table 90. Intervax BCG Tuberculosis (TB) Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Intervax BCG Tuberculosis (TB) Vaccine Product Portfolio Table 92. Intervax Recent Development Table 93. GSBPL Company Information Table 94. GSBPL Business Overview Table 95. GSBPL BCG Tuberculosis (TB) Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. GSBPL BCG Tuberculosis (TB) Vaccine Product Portfolio Table 97. GSBPL Recent Development Table 98. Key Raw Materials Table 99. Raw Materials Key Suppliers Table 100. BCG Tuberculosis (TB) Vaccine Distributors List Table 101. BCG Tuberculosis (TB) Vaccine Customers List Table 102. Research Programs/Design for This Report Table 103. Authors List of This Report Table 104. Secondary Sources Table 105. Primary Sources List of Figures Figure 1. BCG Tuberculosis (TB) Vaccine Product Image Figure 2. Global BCG Tuberculosis (TB) Vaccine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global BCG Tuberculosis (TB) Vaccine Sales Value (2021-2032) & (US$ Million) Figure 4. Global BCG Tuberculosis (TB) Vaccine Sales (2021-2032) & (k units) Figure 5. Global BCG Tuberculosis (TB) Vaccine Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global BCG Tuberculosis (TB) Vaccine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Immune BCG Image Figure 10. Therapy BCG Image Figure 11. Global BCG Tuberculosis (TB) Vaccine Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global BCG Tuberculosis (TB) Vaccine Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global BCG Tuberculosis (TB) Vaccine Sales Volume Share by Type (2021-2032) Figure 14. Global BCG Tuberculosis (TB) Vaccine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global BCG Tuberculosis (TB) Vaccine Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global BCG Tuberculosis (TB) Vaccine Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Global BCG Tuberculosis (TB) Vaccine Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global BCG Tuberculosis (TB) Vaccine Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global BCG Tuberculosis (TB) Vaccine Sales Volume Share by Application (2021-2032) Figure 22. Global BCG Tuberculosis (TB) Vaccine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global BCG Tuberculosis (TB) Vaccine Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global BCG Tuberculosis (TB) Vaccine Sales Value Share by Application (2021-2032) Figure 25. Global BCG Tuberculosis (TB) Vaccine Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 26. Global BCG Tuberculosis (TB) Vaccine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global BCG Tuberculosis (TB) Vaccine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global BCG Tuberculosis (TB) Vaccine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America BCG Tuberculosis (TB) Vaccine Sales Value (2021-2032) & (US$ Million) Figure 30. North America BCG Tuberculosis (TB) Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe BCG Tuberculosis (TB) Vaccine Sales Value (2021-2032) & (US$ Million) Figure 32. Europe BCG Tuberculosis (TB) Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific BCG Tuberculosis (TB) Vaccine Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific BCG Tuberculosis (TB) Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America BCG Tuberculosis (TB) Vaccine Sales Value (2021-2032) & (US$ Million) Figure 36. South America BCG Tuberculosis (TB) Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa BCG Tuberculosis (TB) Vaccine Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa BCG Tuberculosis (TB) Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA BCG Tuberculosis (TB) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA BCG Tuberculosis (TB) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA BCG Tuberculosis (TB) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada BCG Tuberculosis (TB) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada BCG Tuberculosis (TB) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada BCG Tuberculosis (TB) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico BCG Tuberculosis (TB) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico BCG Tuberculosis (TB) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico BCG Tuberculosis (TB) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany BCG Tuberculosis (TB) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany BCG Tuberculosis (TB) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany BCG Tuberculosis (TB) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France BCG Tuberculosis (TB) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France BCG Tuberculosis (TB) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France BCG Tuberculosis (TB) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. BCG Tuberculosis (TB) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. BCG Tuberculosis (TB) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. BCG Tuberculosis (TB) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy BCG Tuberculosis (TB) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy BCG Tuberculosis (TB) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy BCG Tuberculosis (TB) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain BCG Tuberculosis (TB) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain BCG Tuberculosis (TB) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain BCG Tuberculosis (TB) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia BCG Tuberculosis (TB) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia BCG Tuberculosis (TB) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia BCG Tuberculosis (TB) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands BCG Tuberculosis (TB) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands BCG Tuberculosis (TB) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands BCG Tuberculosis (TB) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries BCG Tuberculosis (TB) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries BCG Tuberculosis (TB) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries BCG Tuberculosis (TB) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China BCG Tuberculosis (TB) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China BCG Tuberculosis (TB) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China BCG Tuberculosis (TB) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan BCG Tuberculosis (TB) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan BCG Tuberculosis (TB) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan BCG Tuberculosis (TB) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea BCG Tuberculosis (TB) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea BCG Tuberculosis (TB) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea BCG Tuberculosis (TB) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India BCG Tuberculosis (TB) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India BCG Tuberculosis (TB) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India BCG Tuberculosis (TB) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia BCG Tuberculosis (TB) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia BCG Tuberculosis (TB) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia BCG Tuberculosis (TB) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia BCG Tuberculosis (TB) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia BCG Tuberculosis (TB) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia BCG Tuberculosis (TB) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil BCG Tuberculosis (TB) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil BCG Tuberculosis (TB) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil BCG Tuberculosis (TB) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina BCG Tuberculosis (TB) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina BCG Tuberculosis (TB) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina BCG Tuberculosis (TB) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile BCG Tuberculosis (TB) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile BCG Tuberculosis (TB) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile BCG Tuberculosis (TB) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia BCG Tuberculosis (TB) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia BCG Tuberculosis (TB) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia BCG Tuberculosis (TB) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru BCG Tuberculosis (TB) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru BCG Tuberculosis (TB) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru BCG Tuberculosis (TB) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia BCG Tuberculosis (TB) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia BCG Tuberculosis (TB) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia BCG Tuberculosis (TB) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel BCG Tuberculosis (TB) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia BCG Tuberculosis (TB) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia BCG Tuberculosis (TB) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE BCG Tuberculosis (TB) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE BCG Tuberculosis (TB) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE BCG Tuberculosis (TB) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey BCG Tuberculosis (TB) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey BCG Tuberculosis (TB) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey BCG Tuberculosis (TB) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran BCG Tuberculosis (TB) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran BCG Tuberculosis (TB) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran BCG Tuberculosis (TB) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt BCG Tuberculosis (TB) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt BCG Tuberculosis (TB) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt BCG Tuberculosis (TB) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. BCG Tuberculosis (TB) Vaccine Value Chain Figure 124. Manufacturing Cost Structure Figure 125. BCG Tuberculosis (TB) Vaccine Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Immune BCG
  • Therapy BCG
Applications
  • Hospital
  • Clinic
Companies covered
  • China National Biotec
  • Sanofi Pasteur
  • Merck
  • Serum Institute of India
  • Japan BCG Lab
  • Intervax
  • GSBPL

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global BCG Tuberculosis (TB) Vaccine Sales Value (2021-2032)
  4. 1.2.2 Global BCG Tuberculosis (TB) Vaccine Sales Volume (2021-2032)
  5. 1.2.3 Global BCG Tuberculosis (TB) Vaccine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 BCG Tuberculosis (TB) Vaccine Market Dynamics
  1. 2.1 BCG Tuberculosis (TB) Vaccine Industry Trends
  2. 2.2 BCG Tuberculosis (TB) Vaccine Industry Drivers
  3. 2.3 BCG Tuberculosis (TB) Vaccine Industry Opportunities and Challenges
  4. 2.4 BCG Tuberculosis (TB) Vaccine Industry Restraints
3 BCG Tuberculosis (TB) Vaccine Market by Company
  1. 3.1 Global BCG Tuberculosis (TB) Vaccine Company Revenue Ranking in 2025
  2. 3.2 Global BCG Tuberculosis (TB) Vaccine Revenue by Company (2021-2026)
  3. 3.3 Global BCG Tuberculosis (TB) Vaccine Sales Volume by Company (2021-2026)
  4. 3.4 Global BCG Tuberculosis (TB) Vaccine Average Price by Company (2021-2026)
  5. 3.5 Global BCG Tuberculosis (TB) Vaccine Company Ranking (2024-2026)
  6. 3.6 Global BCG Tuberculosis (TB) Vaccine Company Manufacturing Base and Headquarters
  7. 3.7 Global BCG Tuberculosis (TB) Vaccine Company Product Type and Application
  8. 3.8 Global BCG Tuberculosis (TB) Vaccine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global BCG Tuberculosis (TB) Vaccine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 BCG Tuberculosis (TB) Vaccine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 BCG Tuberculosis (TB) Vaccine Market by Type
  1. 4.1 BCG Tuberculosis (TB) Vaccine Type Introduction
  2. 4.1.1 Immune BCG
  3. 4.1.2 Therapy BCG
  4. 4.2 Global BCG Tuberculosis (TB) Vaccine Sales Volume by Type
  5. 4.2.1 Global BCG Tuberculosis (TB) Vaccine Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global BCG Tuberculosis (TB) Vaccine Sales Volume by Type (2021-2032)
  7. 4.2.3 Global BCG Tuberculosis (TB) Vaccine Sales Volume Share by Type (2021-2032)
  8. 4.3 Global BCG Tuberculosis (TB) Vaccine Sales Value by Type
  9. 4.3.1 Global BCG Tuberculosis (TB) Vaccine Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global BCG Tuberculosis (TB) Vaccine Sales Value by Type (2021-2032)
  11. 4.3.3 Global BCG Tuberculosis (TB) Vaccine Sales Value Share by Type (2021-2032)
5 BCG Tuberculosis (TB) Vaccine Market by Application
  1. 5.1 BCG Tuberculosis (TB) Vaccine Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global BCG Tuberculosis (TB) Vaccine Sales Volume by Application
  5. 5.2.1 Global BCG Tuberculosis (TB) Vaccine Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global BCG Tuberculosis (TB) Vaccine Sales Volume by Application (2021-2032)
  7. 5.2.3 Global BCG Tuberculosis (TB) Vaccine Sales Volume Share by Application (2021-2032)
  8. 5.3 Global BCG Tuberculosis (TB) Vaccine Sales Value by Application
  9. 5.3.1 Global BCG Tuberculosis (TB) Vaccine Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global BCG Tuberculosis (TB) Vaccine Sales Value by Application (2021-2032)
  11. 5.3.3 Global BCG Tuberculosis (TB) Vaccine Sales Value Share by Application (2021-2032)
6 BCG Tuberculosis (TB) Vaccine Regional Sales and Value Analysis
  1. 6.1 Global BCG Tuberculosis (TB) Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global BCG Tuberculosis (TB) Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global BCG Tuberculosis (TB) Vaccine Sales by Region: 2021-2026
  4. 6.2.2 Global BCG Tuberculosis (TB) Vaccine Sales by Region (2027-2032)
  5. 6.3 Global BCG Tuberculosis (TB) Vaccine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global BCG Tuberculosis (TB) Vaccine Sales Value by Region (2021-2032)
  7. 6.4.1 Global BCG Tuberculosis (TB) Vaccine Sales Value by Region: 2021-2026
  8. 6.4.2 Global BCG Tuberculosis (TB) Vaccine Sales Value by Region (2027-2032)
  9. 6.5 Global BCG Tuberculosis (TB) Vaccine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America BCG Tuberculosis (TB) Vaccine Sales Value (2021-2032)
  12. 6.6.2 North America BCG Tuberculosis (TB) Vaccine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe BCG Tuberculosis (TB) Vaccine Sales Value (2021-2032)
  15. 6.7.2 Europe BCG Tuberculosis (TB) Vaccine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific BCG Tuberculosis (TB) Vaccine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific BCG Tuberculosis (TB) Vaccine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America BCG Tuberculosis (TB) Vaccine Sales Value (2021-2032)
  21. 6.9.2 South America BCG Tuberculosis (TB) Vaccine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa BCG Tuberculosis (TB) Vaccine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa BCG Tuberculosis (TB) Vaccine Sales Value Share by Country, 2025 VS 2032
7 BCG Tuberculosis (TB) Vaccine Country-level Sales and Value Analysis
  1. 7.1 Global BCG Tuberculosis (TB) Vaccine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global BCG Tuberculosis (TB) Vaccine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global BCG Tuberculosis (TB) Vaccine Sales by Country (2021-2032)
  4. 7.3.1 Global BCG Tuberculosis (TB) Vaccine Sales by Country (2021-2026)
  5. 7.3.2 Global BCG Tuberculosis (TB) Vaccine Sales by Country (2027-2032)
  6. 7.4 Global BCG Tuberculosis (TB) Vaccine Sales Value by Country (2021-2032)
  7. 7.4.1 Global BCG Tuberculosis (TB) Vaccine Sales Value by Country (2021-2026)
  8. 7.4.2 Global BCG Tuberculosis (TB) Vaccine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA BCG Tuberculosis (TB) Vaccine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA BCG Tuberculosis (TB) Vaccine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA BCG Tuberculosis (TB) Vaccine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada BCG Tuberculosis (TB) Vaccine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada BCG Tuberculosis (TB) Vaccine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada BCG Tuberculosis (TB) Vaccine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico BCG Tuberculosis (TB) Vaccine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico BCG Tuberculosis (TB) Vaccine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico BCG Tuberculosis (TB) Vaccine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany BCG Tuberculosis (TB) Vaccine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany BCG Tuberculosis (TB) Vaccine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany BCG Tuberculosis (TB) Vaccine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France BCG Tuberculosis (TB) Vaccine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France BCG Tuberculosis (TB) Vaccine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France BCG Tuberculosis (TB) Vaccine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. BCG Tuberculosis (TB) Vaccine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. BCG Tuberculosis (TB) Vaccine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. BCG Tuberculosis (TB) Vaccine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy BCG Tuberculosis (TB) Vaccine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy BCG Tuberculosis (TB) Vaccine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy BCG Tuberculosis (TB) Vaccine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain BCG Tuberculosis (TB) Vaccine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain BCG Tuberculosis (TB) Vaccine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain BCG Tuberculosis (TB) Vaccine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia BCG Tuberculosis (TB) Vaccine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia BCG Tuberculosis (TB) Vaccine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia BCG Tuberculosis (TB) Vaccine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands BCG Tuberculosis (TB) Vaccine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands BCG Tuberculosis (TB) Vaccine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands BCG Tuberculosis (TB) Vaccine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries BCG Tuberculosis (TB) Vaccine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries BCG Tuberculosis (TB) Vaccine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries BCG Tuberculosis (TB) Vaccine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China BCG Tuberculosis (TB) Vaccine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China BCG Tuberculosis (TB) Vaccine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China BCG Tuberculosis (TB) Vaccine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan BCG Tuberculosis (TB) Vaccine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan BCG Tuberculosis (TB) Vaccine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan BCG Tuberculosis (TB) Vaccine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea BCG Tuberculosis (TB) Vaccine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea BCG Tuberculosis (TB) Vaccine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea BCG Tuberculosis (TB) Vaccine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India BCG Tuberculosis (TB) Vaccine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India BCG Tuberculosis (TB) Vaccine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India BCG Tuberculosis (TB) Vaccine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia BCG Tuberculosis (TB) Vaccine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia BCG Tuberculosis (TB) Vaccine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia BCG Tuberculosis (TB) Vaccine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia BCG Tuberculosis (TB) Vaccine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia BCG Tuberculosis (TB) Vaccine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia BCG Tuberculosis (TB) Vaccine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil BCG Tuberculosis (TB) Vaccine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil BCG Tuberculosis (TB) Vaccine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil BCG Tuberculosis (TB) Vaccine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina BCG Tuberculosis (TB) Vaccine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina BCG Tuberculosis (TB) Vaccine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina BCG Tuberculosis (TB) Vaccine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile BCG Tuberculosis (TB) Vaccine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile BCG Tuberculosis (TB) Vaccine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile BCG Tuberculosis (TB) Vaccine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia BCG Tuberculosis (TB) Vaccine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia BCG Tuberculosis (TB) Vaccine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia BCG Tuberculosis (TB) Vaccine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru BCG Tuberculosis (TB) Vaccine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru BCG Tuberculosis (TB) Vaccine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru BCG Tuberculosis (TB) Vaccine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia BCG Tuberculosis (TB) Vaccine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia BCG Tuberculosis (TB) Vaccine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia BCG Tuberculosis (TB) Vaccine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel BCG Tuberculosis (TB) Vaccine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel BCG Tuberculosis (TB) Vaccine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel BCG Tuberculosis (TB) Vaccine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE BCG Tuberculosis (TB) Vaccine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE BCG Tuberculosis (TB) Vaccine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE BCG Tuberculosis (TB) Vaccine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey BCG Tuberculosis (TB) Vaccine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey BCG Tuberculosis (TB) Vaccine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey BCG Tuberculosis (TB) Vaccine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran BCG Tuberculosis (TB) Vaccine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran BCG Tuberculosis (TB) Vaccine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran BCG Tuberculosis (TB) Vaccine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt BCG Tuberculosis (TB) Vaccine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt BCG Tuberculosis (TB) Vaccine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt BCG Tuberculosis (TB) Vaccine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 China National Biotec
  2. 8.1.1 China National Biotec Company Information
  3. 8.1.2 China National Biotec Business Overview
  4. 8.1.3 China National Biotec BCG Tuberculosis (TB) Vaccine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 China National Biotec BCG Tuberculosis (TB) Vaccine Product Portfolio
  6. 8.1.5 China National Biotec Recent Developments
  7. 8.2 Sanofi Pasteur
  8. 8.2.1 Sanofi Pasteur Company Information
  9. 8.2.2 Sanofi Pasteur Business Overview
  10. 8.2.3 Sanofi Pasteur BCG Tuberculosis (TB) Vaccine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Sanofi Pasteur BCG Tuberculosis (TB) Vaccine Product Portfolio
  12. 8.2.5 Sanofi Pasteur Recent Developments
  13. 8.3 Merck
  14. 8.3.1 Merck Company Information
  15. 8.3.2 Merck Business Overview
  16. 8.3.3 Merck BCG Tuberculosis (TB) Vaccine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Merck BCG Tuberculosis (TB) Vaccine Product Portfolio
  18. 8.3.5 Merck Recent Developments
  19. 8.4 Serum Institute of India
  20. 8.4.1 Serum Institute of India Company Information
  21. 8.4.2 Serum Institute of India Business Overview
  22. 8.4.3 Serum Institute of India BCG Tuberculosis (TB) Vaccine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Serum Institute of India BCG Tuberculosis (TB) Vaccine Product Portfolio
  24. 8.4.5 Serum Institute of India Recent Developments
  25. 8.5 Japan BCG Lab
  26. 8.5.1 Japan BCG Lab Company Information
  27. 8.5.2 Japan BCG Lab Business Overview
  28. 8.5.3 Japan BCG Lab BCG Tuberculosis (TB) Vaccine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Japan BCG Lab BCG Tuberculosis (TB) Vaccine Product Portfolio
  30. 8.5.5 Japan BCG Lab Recent Developments
  31. 8.6 Intervax
  32. 8.6.1 Intervax Company Information
  33. 8.6.2 Intervax Business Overview
  34. 8.6.3 Intervax BCG Tuberculosis (TB) Vaccine Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Intervax BCG Tuberculosis (TB) Vaccine Product Portfolio
  36. 8.6.5 Intervax Recent Developments
  37. 8.7 GSBPL
  38. 8.7.1 GSBPL Company Information
  39. 8.7.2 GSBPL Business Overview
  40. 8.7.3 GSBPL BCG Tuberculosis (TB) Vaccine Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 GSBPL BCG Tuberculosis (TB) Vaccine Product Portfolio
  42. 8.7.5 GSBPL Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 BCG Tuberculosis (TB) Vaccine Value Chain Analysis
  2. 9.1.1 BCG Tuberculosis (TB) Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 BCG Tuberculosis (TB) Vaccine Sales Mode & Process
  6. 9.2 BCG Tuberculosis (TB) Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 BCG Tuberculosis (TB) Vaccine Distributors
  9. 9.2.3 BCG Tuberculosis (TB) Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst